The CDC's vaccines panel has voted to revoke an earlier recommendation to allow parents to choose whether to give measles, mumps, and rubella (MMR) and varicella (V) vaccines in one or two doses, but ...
A big part of Biogen's efforts to defend its spinal muscular atrophy (SMA) business has been dealt a setback by the FDA, which declined to approve a high-dose version of its flagship Spinraza product.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback